Results 31 to 40 of about 230,109 (316)

The Global Expansion of Dengue: How Aedes aegypti Mosquitoes Enabled the First Pandemic Arbovirus.

open access: yesAnnual Review of Entomology, 2020
Dengue is an emerging viral disease principally transmitted by the Aedes (Stegomyia) aegypti mosquito. It is one of the fastest-growing global infectious diseases, with 100-400 million new infections a year, and is now entrenched in a growing number of ...
O. Brady, Simon Iain Hay
semanticscholar   +1 more source

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection

open access: yesNature Communications, 2018
The antibody response during infection with dengue virus is a key component involved in the pathogenesis during secondary infection. Here the authors show antibodies targeting NS1 and the epitopes targeted can be associated with disease severity during ...
Deshni Jayathilaka   +10 more
doaj   +1 more source

DIFFERENCES OF UNIVERSAL AND MULTIPLEX PRIMER FOR DETECTION OF DENGUE VIRUS FROM PATIENTS SUSPECTED DENGUE HEMORRHAGIC FEVER (DHF) IN SURABAYA

open access: yesIndonesian Journal of Tropical and Infectious Disease, 2015
Dengue Hemorrhagic Fever (DHF) is a global health problem in tropical and subtropical regions, as well as endemic in110 countries around the world. Indonesia is one of the largest countries in the region of endemic dengue.
Arif Ansori   +6 more
doaj   +1 more source

Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication

open access: yesMolecules, 2021
Dengue fever is one of the most common viral infections affecting humans. It is an expanding public health problem, particularly in tropical and subtropical regions.
Kingshuk Panda   +2 more
doaj   +1 more source

Seroprevalence and incidence of primary dengue infections among children in a rural region of Maharashtra, Western India

open access: yesBMC Infectious Diseases, 2019
Background Dengue infections have become a huge threat to public health systems in developing countries. Data on seroprevalence and incidence of dengue infections are lacking from rural regions of India.
Paresh S. Shah   +8 more
doaj   +1 more source

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness

open access: yesScientific Reports, 2021
In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing antibodies (NAbs), and their association with clinical disease severity ...
Chandima Jeewandara   +12 more
doaj   +1 more source

Identification of Novel Candidate CD8+ T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses

open access: yesViruses, 2021
Cross-reactive T cell immunity to seasonal coronaviruses (HCoVs) may lead to immunopathology or protection during SARS-CoV2 infection. To understand the influence of cross-reactive T cell responses, we used IEDB (Immune epitope database) and NetMHCpan ...
Pradeep Darshana Pushpakumara   +5 more
doaj   +1 more source

The impact of dengue on liver function as evaluated by aminotransferase levels

open access: yesBrazilian Journal of Infectious Diseases
The objective of this study was to evaluate the impact of dengue virus infection on liver function by measuring aminotransferase in blood samples from patients serologically diagnosed by according to two MAC-ELISA protocols.
Luiz José de Souza   +7 more
doaj   +1 more source

Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses

open access: yesViruses, 2021
Dengue is a mosquito-borne viral disease (arboviral) caused by the Dengue virus. It is one of the prominent public health problems in tropical and subtropical regions with no effective vaccines.
Nikita Nanaware   +4 more
semanticscholar   +1 more source

Hemorrhagic encephalopathy in dengue shock syndrome: a case report

open access: yesBrazilian Journal of Infectious Diseases
Dengue fever is the most important arboviral infection in the world, with an estimated 100 million cases per year and 2.5 billion people at risk.
Luiz José de Souza   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy